LDN – a potential Game Changer for Colitis or Crohn’s Disease
The month of November has been observed across Canada as Crohn’s & Colitis Awareness Month and we want to do our part to raise awareness and educate the public about a new promising treatment option for Crohn’s and Colitis.Low Dose Naltrexone (LDN) is a drug that can provide therapeutic benefits for many chronic conditions. LDN […]
Rheumatoid Arthritis and Low Dose Naltrexone (LDN)
Rheumatoid arthritis (RA) is an inflammatory disease that can affect multiple joints in the body. RA is an autoimmune disease where the body’s immune system—which usually functions to protect us against infections—mistakenly attacks the lining of the joints. Rheumatoid Arthritis is most often associated with chronic inflammation. This inflammation in the joints causes pain, stiffness and […]
First, what is Naltrexone?Naltrexone is a drug that was approved in 1997 by Health Canada (1984 by the FDA in the US) in a 50mg dose for the purpose of reducing the euphoric effects of alcohol. Naltrexone not only helps patients achieve abstinence, but it is also a very competitive antagonist of opioid receptors thus having the ability to rescue […]